Kukoamine A inhibits human glioblastoma cell growth and migration through apoptosis induction and epithelial-mesenchymal transition attenuation

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wang, Qiaoping ^a   Li, Haiyan ^a   Sun, Zhen ^a   Dong, Lihua ^a   Gao, Ling ^a   Liu, Chunlan ^a   Wang, Xiujie ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

KUKOAMINE A; SPERMINE; TUMOR PROTEIN;

ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; CELL MOTION; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; G1 PHASE CELL CYCLE CHECKPOINT; GENETICS; GLIOBLASTOMA; HUMAN; METABOLISM; PATHOLOGY; RAT; TUMOR INVASION;

ANIMALS; APOPTOSIS; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; G1 PHASE CELL CYCLE CHECKPOINTS; GLIOBLASTOMA; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RATS; SPERMINE;

EID: 84994448346     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep36543     Document Type: Article

References (50)

1. Lima, F. R. et al. Glioblastoma: therapeutic challenges, what lies ahead. Biochim. Biophys. Acta. 1826, 338-349 (2012).
2. Kubelt, C., Hattermann, K., Sebens, S., Mehdorn, H. M. & Held-Feindt, J. Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas. Int. J. Oncol. 46, 2515-2525 (2015).
3. Le, A. P. et al. Plexin-B2 promotes invasive growth of malignant glioma. Oncotarget 6, 7293-7304 (2015).
4. Fathima Hurmath, K., Palaniswamy, R. & Nandakumar, D. N. IL-1β microenvironment promotes proliferation, migration, and invasion of human glioma cells. Cell Biol. Int. 38, 1415-1422 (2014).
5. Cuddapah, V. A., Robel, S., Watkins, S. & Sontheimer, H. A neurocentric perspective on glioma invasion. Nat. Rev. Neurosci. 15, 455-465 (2014).
6. Cheng, Y. et al. Arsenic trioxide inhibits glioma cell growth through induction of telomerase displacement and telomere dysfunction. Oncotarget. 7, 12682-12692 (2016).
7. Kushal, S. et al. Monoamine oxidase A (MAO A) inhibitors decrease glioma progression. Oncotarget. 7, 13842-13853 (2016).
8. Karpel-Massler, G. et al. Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo. Oncotarget. 7, 12791-12805 (2016).
9. Sesen, J. et al. Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response. Plos One 10, e0123721 (2015).
10. Wang, W. X., Sun, Z. H., Chen, H. M., Xu, B. N. & Wang, F. Y. Role and mechanism of Sophoridine on proliferation inhibition in human glioma U87MG cell line. Int. J. Clin. Exp. Med. 8, 464-471 (2015).
11. David, C. N. et al. Antitumor activity of a polypyridyl chelating ligand: in vitro and in vivo inhibition of glioma. ASN Neuro. 7, 1759091415572365 (2015).
12. Huasong, G. et al. Serine protease inhibitor (SERPIN) B1 suppresses cell migration and invasion in glioma cells. Brain Res. 1600, 59-69 (2015).
13. Zhang, Z. et al. Baicalein reduces the invasion of glioma cells via reducing the activity of p38 signaling pathway. Plos One 9, e90318 (2014).
14. Liu, X. et al. Plumbagin induces growth inhibition of human glioma cells by downregulating the expression and activity of FOXM1. J. Neurooncol. 121, 469-477 (2015).
15. Tezcan, G. et al. Ficus carica latex prevents invasion through induction of let-7d expression in GBM cell lines. Cell Mol. Neurobiol. 35, 175-187 (2015).
16. Jeong, J. C., Kim. S. J., Kim, Y. K., Kwon, C. H. & Kim, K. H. Lycii cortex radicis extract inhibits glioma tumor growth in vitro and in vivo through downregulation of the Akt/ERK pathway. Oncol. Rep. 27, 1467-1474 (2012).
17. Kim, J. H. et al. The effects of Lycii Radicis Cortex on RANKL-induced osteoclast differentiation and activation in RAW 264.7 cells. Int. J. Mol. Med. 37, 649-658 (2016).
18. Hadjipavlou-Litina, D., Garnelis, T., Athanassopoulos, C. M. & Papaioannou, D. Kukoamine A analogs with lipoxygenase inhibitory activity. J. Enzyme. Inhib. Med. Chem. 24, 1188-1193 (2009).
19. Hu, X. L. et al. Neuroprotection by Kukoamine A against oxidative stress may involve N-methyl-D-aspartate receptors. Biochim. Biophys. Acta 1850, 287-298 (2015).
20. Sathya, R. K. et al. Anti-cancer activity of 2,4-disubstituted thiophene derivatives: Dual inhibitors of lipoxygenase and cyclooxygenase. Med. Chem. Med. Chem. 11, 462-472 (2015).
21. Wang, X. et al. Co-expression of COX-2 and 5-LO in primary glioblastoma is associated with poor prognosis. J. Neurooncol. 125, 277-285 (2015).
22. Nathoo, N. et al. Increased expression of 5-lipoxygenase in high-grade astrocytomas. Neurosurgery 58, 347-354 (2006).
23. Morin, P. Jr. et al. NMR metabolomics analysis of the effects of 5-lipoxygenase inhibitors on metabolism in glioblastomas. J. Proteome. Res. 12, 2165-2176 (2013).
24. Woo, J. S., Kim, S. M., Jeong, C. H., Ryu, C. H. & Jeun, S. S. Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma. Biochem. Biophys. Res. Commun. 431, 354-359 (2013).
25. Ishii, K., Zaitsu, M., Yonemitsu, N., Kan, Y., Hamasaki, Y. & Matsuo, M. 5-lipoxygenase pathway promotes cell proliferation in human glioma cell lines. Clin. Neuropathol. 28, 445-452 (2009).
26. Lim, J. Y. et al. MK886-induced apoptosis depends on the 5-LO expression level in human malignant glioma cells. J. Neurooncol. 97, 339-346 (2010).
27. Venugopala, K. N. et al. Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents. Drug Des. Devel. Ther. 9, 911-921 (2015).
28. Chen, W. L. et al. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion. Oncotarget 6, 16321-16340 (2015).
29. Peng, G. et al. miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL. Mol. Cell Biochem 409, 103-111 (2015).
30. Gilbert, B. et al. 5-Lipoxygenase is a direct p53 target gene in humans. Biochim. Biophys. Acta 1849, 1003-1016 (2015).
31. Bishayee, K. & Khuda-Bukhsh, A. R. 5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy. Acta Biochim. Biophys. Sin. (Shanghai). 45, 709-719 (2013).
32. Wagenknecht, B., Gulbins, E., Lang, F., Dichgans, J. & Weller, M. Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells. FEBS Lett. 409, 17-23 (1997).
33. Shin, V. Y. et al. Activation of 5-lipoxygenase is required for nicotine mediated epithelial-mesenchymal transition and tumor cell growth. Cancer Lett. 292, 237-245 (2010).
34. Carro, M. S. et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 463, 318-325 (2010).
35. Lee, J. K., Joo, K. M., Lee, J., Yoon, Y. & Nam, D. H. Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling. Onco. Targets Ther. 7, 1933-1944 (2014).
36. Aguilar-Morante, D., Cortes-Canteli, M., Sanz-Sancristobal, M., Santos, A. & Perez-Castillo, A. Decreased CCAAT/enhancer binding protein β expression inhibits the growth of glioblastoma cells. Neuroscience 176, 110-119 (2011).
37. Homma, J. et al. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients. Oncol. Rep. 15, 595-601 (2006).
38. Aguilar-Morante, D., Morales-Garcia, J. A., Santos, A. & Perez-Castillo, A. CCAAT/enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4. Oncotarget 6, 4369-4384 (2015).
39. Lin, J. J. et al. Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition. Oncotarget 6, 17107-17120 (2015).
40. Mikheeva, S. A. et al. TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol. Cancer 9, 194 (2010).
41. Myung, J. K., Choi, S. A., Kim, S. K., Wang, K. C. & Park, S. H. Snail plays an oncogenic role in glioblastoma by promoting epithelial mesenchymal transition. Int. J. Clin. Exp. Pathol. 7, 1977-1987 (2014).
42. Catalano, M. et al. Autophagy induction impairs migration and invasion by reversing EMT in glioblastoma cells. Mol. Oncol. 9, 1612-1625 (2015).
43. Han, S. P. et al. SNAI1 is involved in the proliferation and migration of glioblastoma cells. Cell Mol. Neurobiol. 31, 489-496 (2011).
44. Wang, J. et al. Establishment of a New Human Glioblastoma Multiforme Cell Line (WJ1) and Its Partial Characterization. Cell Mol. Neurobiol. 27, 831-843 (2007).
45. van Meerloo, J., Kaspers, G. J. & Cloos, J. Cell sensitivity assays: the MTT assay. Methods Mol. Biol. 731, 237-245 (2011).
46. Kim, M. J. et al. Apoptotic effect of red wine polyphenols on human colon cancer SNU-C4 cells. Food. Chem. Toxicol. 44, 898-902 (2006).
47. Sun, L. et al. Silence of MACC1 expression by RNA interference inhibits proliferation, invasion and metastasis, and promotes apoptosis in U251 human malignant glioma cells. Mol. Med. Rep. 12, 3423-3431 (2015).
48. Liu, K., Liu, P. C., Liu, R. & Wu, X. Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry. Med. Sci. Monit. Basic. Res. 21, 15-20 (2015).
49. Thompson, C. C. et al. Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut 56, 95-106 (2007).
50. Tsai, C. H. et al. Herbal extract of Wedelia chinensis attenuates androgen receptor activity and orthotopic growth of prostate cancer in nude mice. Clin. Cancer Res. 15, 5435-5444 (2009).